The Verapamil in Hypertension and Atherosclerosis Study (VHAS): Results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness

Journal of Hypertension

Volumn 16, Issue 11, 1998, Pages 1667-1676

  Zanchetti, Alberto ^a,e   Agabiti Rosei, Enrico ^b   Dal Palù, Cesare ^c   Leonetti, Gastone ^a   Magnani, Bruno ^d   Pessina, Achille ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Antihypertensive treatment; Atherosclerosis; Carotid intima media thickness; Randomized therapeutic study; Verapamil

Indexed keywords

CHLORTALIDONE; VERAPAMIL;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; B SCAN; CLINICAL TRIAL; COMMON CAROTID ARTERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; INTERNAL CAROTID ARTERY; ITALY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0031768673     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816110-00014     Document Type: Article

References (36)

1. O'Leary DR, Polak JF, Kronmal RA, Kittner SJ, Bond MG, Wolfson SK, et al. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. Stroke 1992; 23:1752-1760.
2. Veller MG, Fisher CM, Nicolaides AN, Renton S, Geroulakos C, Stafford NJ, et al. Measurement of the ultrasonic intima-media complex thickness in normal subjects. J Vasc Surg 1993; 17:719-725.
3. Howard G, Sharrett AR, Heiss G, Rantala AO, Kiema TR, Lilja M, et al. Carotid artery intimai medial thickness distribution in general populations as evaluated by B-mode ultrasound. Stroke 1993; 24:1297-1304.
4. Kauma H, Päivänsalo M, Savolainen MJ, Rantala AO, Kiema TR, Lilja M, et al. Association between angiotensin converting enzyme gene polymorphism and carotid atherosclerosis. J Hypertens 1996; 14:1183-1187.
5. Päivänsalo M, Rantala AO, Kauma H, Lilja M, Reunanen A, Savolainen MJ, et al. Prevalence of carotid atherosclerosis in middle-aged hypertensive and control subjects: a cross-sectional systematic study with duplex ultrasound. J Hypertens 1996; 14:1433-1439.
6. Salonen JT, Salonen R. Risk factors for carotid and femoral atherosclerosis in hypercholesterolaemic men. J Intern Med 1994; 236:561-566.
7. Zanchetti A, Bond MG, Henning M, Neiss A, Mancia G, Dal Palù C, et al. Prevalence and risk factors of carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 1998; 16:949-961.
8. Lusiani L, Visona A, Castellani V, Ronsisvalle G, Scaldalai E, Carraro L, et al. Prevalence of atherosclerotic involvement of the internal carotid artery in hypertensive patients. Int J Cardiol 1987; 17:51-56.
9. Crouse JR, Toole JF, McKinney WM, Dignan MB, Howard G, Kahl FR, et al. Risk factors for extracranial carotid artery atherosclerosis. Stroke 1987; 18:990-996.
10. O'Leary DH, Anderson KM, Kase CS, Wolf PA, Kannel WB. Extracranial carotid atherosclerosis in a general population. The Framingham Heart Study. Stroke 1988; 19:143-146.
11. Bonithon-Kopp C, Jouven X, Taquet A, Touboul P-J, Guize L, Scarabin P-Y. Early carotid atherosclerosis in healthy middle-aged French women. Stroke 1993; 24:1837-1843.
12. Roman MMJ, Pickering TG, Pini R, Schwartz JE, Devereux RB. Determinants of cardiac and vascular hypertrophy in hypertension. Hypertension 1995; 26:369-373.
13. Muiesan ML, Pasini GF, Salvetti M, Calebich S, Zulli R, Castellano M, et al. Cardiac and vascular structural changes: prevalence and relation to ambulatory blood pressure in a middle aged population in northern Italy. The Vobarno Study. Hypertension 1996; 27:1046-1053.
14. Poli A, Tremoli E, Colombo A, Sirtori M, Pignoli P, Paoletti R. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients. Atherosclerosis 1988; 70:253-261.
15. Folson A, Eckfeldt J, Weitzman S, Ma J, Chambless L, Barnes R, et al., for the ARIC Investigators. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size and physical activity. Stroke 1994; 25:66-73.
16. Burke GL, Evans GW, Riley WA, Sharrett AR, Howard G, Barnes RW, et al., for the ARIC Study Group. Arterial wall thickness is associated with prevalent cardiovascular diseases in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) study. Stroke 1995; 26:386-391.
17. Bond G, Wilmoth SK, Enevold GL, Strickland HL. Detection and monitoring of asymptomatic atherosclerosis in clinical trials. Am J Med 1989; 86 (suppl 4A):33-36
18. Mercuri M, Devi K. Quantitative ultrasonographic evaluation of the carotid arteries in hypertension. J Cardiovasc Risk 1995; 2:27-33.
19. Zanchetti A. Trials investigating the anti-atherosclerotic effects of antihypertensive drugs. J Hypertens 1996; 14 (suppl 2):S77-S81.
20. Borhani N, Mercuri M, Borhani P, Buckalew V, Canossa-Terns M, Carr A, et al. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS): a randomized controlled trial. JAMA 1996; 276:785-791.
21. Hansson L, Zanchetti A. The antiatherosclerotic effect of calcium antagonists in man: what did MIDAS actually show? Blood Press 1995; 4:133-136.
22. Zanchetti A. Evaluating the benefits of an antihypertensive agent using trials based on event and organ damage: the Systolic Hypertension in the Elderly Long-term Lacidipine (SHELL) trial and the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 1995; 13 (suppl 4): S35-S39.
23. The Phyllis project group. Plaque Hypertension Lipid-Lowering Italian Study (PHYLLIS): a protocol for non-invasive evaluation of carotid atherosclerosis in hypercholesterolemic hypertensive subjects. J Hypertens 1993; 11 (suppl 5):S314-S315.
24. Agabiti-Rosei E, Dal Palù C, Leonetti G, Magnani B, Pessina A, Zanchetti A, on behalf of the VHAS investigators. Verapamil in Hypertension and Atherosclerosis Study (VHAS): clinical results. J Hypertens 1997; 15:1337-1344.
25. Salonen R, Salonen JT. Carotid atherosclerosis in relation to systolic and diastolic blood pressure: Kuopio lschaemic Heart Disease Risk Factor Study. Ann Intern Med 1991; 23:23-27.
26. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C, and the ARIC investigators. Carotid atherosclerosis measured by B mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidermal 1991; 134:250-256.
27. Sutton TK, Wolfson SK, Kuller LM. Blood pressure treatment slows the progression of carotid stenosis in patients with isolated systolic hypertension. Stroke 1994; 25:44-50.
28. Mercuri M, Bond MG, Sirtori CR, Veglia F, Crepaldi G, Feruglio S, et al. Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic Mediterranean population: the Carotid Atherosclerosis Italian Study. Am J Med 1996; 101:627-634.
29. Zanchetti A. The antiatherogenic effects of antihypertensive drugs: experimental and clinical evidence. Clin Exp Hypertens 1992; A14:307-331.
30. Pauletto P, Sartore S, Giurato L, Scatena M, Tonello M, Scannapieco G, et al. Calcium antagonists and vascular smooth muscle cells in atherogenesis. J Cardiovasc Pharmacol 1993; 19 (suppl 2):S8-S16.
31. Rouleau JL, Parmley WW, Stevens J, Wikman-Coffelt J, Sievers R. Verapamil suppresses atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol 1983; 1:1453-1460.
32. Sievers RE, Rashid T, Garrett J, Blumlein SL, Parmley WW. Verapamil and diet halt progression of atherosclerosis in cholesterol-fed rabbits. Cardiovasc Drugs Ther 1987; 1:65-69.
33. Stender S, Ravn H, Hangegaard M, Kjeldsen K. Effect of verapamil on accumulation of free and esterified cholesterol in the thoracic aorta of cholesterol-fed rabbits. Atherosclerosis 1986; 61:15-23.
34. Hoberg E, Dietz R, Frees U, Katus HA, Rauch B, Schömig A, et al. Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis. Br Heart J 1994; 71:254-260.
35. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 1993; 87 (suppl II): II56-II65.
36. Sutton TK, Alcorn HG, Herzog H, Kelsey SF, Kuller LH. Morbidity, mortality and antihypertensive treatment effects by extent of atherosclerosis in older adults with isolated systolic hypertension. Stroke 1995; 26:1319-1324.